General Statement of Disclosure: CONSULTING FEES/HONORARIA: Alnylam Pharmaceuticals(MODEST) RESEARCH/RESEARCH GRANTS: Alnylam Pharmaceuticals(SIGNIFICANT), Akari Therapeutics(SIGNIFICANT), Pfizer(MODEST) View Full Disclosure